These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37051947)

  • 1. The First Regulatory Clearance of an Open-Source Automated Insulin Delivery Algorithm.
    Braune K; Hussain S; Lal R
    J Diabetes Sci Technol; 2023 Sep; 17(5):1139-1141. PubMed ID: 37051947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance Effect of Adjusting Insulin Sensitivity for Model-Based Automated Insulin Delivery Systems.
    Moscoso-Vasquez M; Fabris C; Breton MD
    J Diabetes Sci Technol; 2023 Nov; 17(6):1470-1481. PubMed ID: 37864340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world evidence on clinical outcomes of people with type 1 diabetes using open-source and commercial automated insulin dosing systems: A systematic review.
    Knoll C; Peacock S; Wäldchen M; Cooper D; Aulakh SK; Raile K; Hussain S; Braune K
    Diabet Med; 2022 May; 39(5):e14741. PubMed ID: 34773301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial.
    Burnside MJ; Lewis DM; Crocket HR; Meier RA; Williman JA; Sanders OJ; Jefferies CA; Faherty AM; Paul RG; Lever CS; Price SKJ; Frewen CM; Jones SD; Gunn TC; Lampey C; Wheeler BJ; de Bock MI
    Diabetes Technol Ther; 2023 Apr; 25(4):250-259. PubMed ID: 36763345
    [No Abstract]   [Full Text] [Related]  

  • 5. The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review.
    Mathieu C; Ahmed W; Gillard P; Cohen O; Vigersky R; de Portu S; Ozdemir Saltik AZ
    Diabetes Technol Ther; 2024 Mar; 26(S3):66-75. PubMed ID: 38377319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged Exercise With an Open-Source Automated Insulin Delivery System: Data of the Exercise Camp 2022 Austria.
    Müller-Korbsch M; Kietaibl AT; Frühwald L; Heer M; Fasching P
    J Diabetes Sci Technol; 2023 May; 17(3):857-859. PubMed ID: 37052045
    [No Abstract]   [Full Text] [Related]  

  • 7. A real-world study of user characteristics, safety and efficacy of open-source closed-loop systems and Medtronic 670G.
    Jeyaventhan R; Gallen G; Choudhary P; Hussain S
    Diabetes Obes Metab; 2021 Aug; 23(8):1989-1994. PubMed ID: 33999488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System.
    Suttiratana SC; Wong JJ; Lanning MS; Dunlap A; Hanes SJ; Hood KK; Lal RA; Naranjo D
    Diabetes Technol Ther; 2022 Jun; 24(6):416-423. PubMed ID: 35099278
    [No Abstract]   [Full Text] [Related]  

  • 9. A case study in open source innovation: developing the Tidepool Platform for interoperability in type 1 diabetes management.
    Neinstein A; Wong J; Look H; Arbiter B; Quirk K; McCanne S; Sun Y; Blum M; Adi S
    J Am Med Inform Assoc; 2016 Mar; 23(2):324-32. PubMed ID: 26338218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Point-Counterpoint: The Need for Do-It-Yourself (DIY) Open Source (OS) AID Systems in Type 1 Diabetes Management.
    Forlenza GP; Tabatabai I; Lewis DM
    Diabetes Technol Ther; 2024 Oct; 26(10):689-699. PubMed ID: 38669472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated Insulin Delivery with SGLT2i Combination Therapy in Type 1 Diabetes.
    Garcia-Tirado J; Farhy L; Nass R; Kollar L; Clancy-Oliveri M; Basu R; Kovatchev B; Basu A
    Diabetes Technol Ther; 2022 Jul; 24(7):461-470. PubMed ID: 35255229
    [No Abstract]   [Full Text] [Related]  

  • 12. Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial.
    Reznik Y; Carvalho M; Fendri S; Prevost G; Chaillous L; Riveline JP; Hanaire H; Dubois S; Houéto P; Pasche H; Mianowska B; Renard E
    Diabetes Obes Metab; 2024 Feb; 26(2):622-630. PubMed ID: 37921083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient Randomized Crossover Comparison of Zone Model Predictive Control Automated Insulin Delivery with Weekly Data Driven Adaptation Versus Sensor-Augmented Pump: Results from the International Diabetes Closed-Loop Trial 4.
    Pinsker JE; Dassau E; Deshpande S; Raghinaru D; Buckingham BA; Kudva YC; Laffel LM; Levy CJ; Church MM; Desrochers H; Ekhlaspour L; Kaur RJ; Levister C; Shi D; Lum JW; Kollman C; Doyle FJ;
    Diabetes Technol Ther; 2022 Sep; 24(9):635-642. PubMed ID: 35549708
    [No Abstract]   [Full Text] [Related]  

  • 14. Beneficial effects of automated insulin delivery over one-year follow-up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics.
    Henry Z; Villar Fimbel S; Bendelac N; Perge K; Thivolet C
    Diabetes Obes Metab; 2024 Feb; 26(2):557-566. PubMed ID: 37905353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Peek Under the Hood: Explaining the MiniMed™ 780G Algorithm with Meal Detection Technology.
    Grosman B; Roy A; Lintereur L; Turksoy K; Benedetti A; Cordero TL; Vigersky RA; McVean J; Rhinehart AS; Cohen O
    Diabetes Technol Ther; 2024 Mar; 26(S3):17-23. PubMed ID: 38377324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Use of Open-Source Automated Insulin Delivery AndroidAPS in Full Closed-Loop Scenario: Pancreas4ALL Randomized Pilot Study.
    Petruzelkova L; Neuman V; Plachy L; Kozak M; Obermannova B; Kolouskova S; Pruhova S; Sumnik Z
    Diabetes Technol Ther; 2023 May; 25(5):315-323. PubMed ID: 36826996
    [No Abstract]   [Full Text] [Related]  

  • 17. [What is the current state of the artificial pancreas in diabetes care?].
    Dimou M; Laimer M; Stettler C; Bally L
    Internist (Berl); 2020 Jan; 61(1):102-109. PubMed ID: 31863132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated insulin dosing systems: Advances after a century of insulin.
    Thabit H; Lal R; Leelarathna L
    Diabet Med; 2021 Dec; 38(12):e14695. PubMed ID: 34547133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System.
    Polonsky WH; Hood KK; Levy CJ; MacLeish SA; Hirsch IB; Brown SA; Bode BW; Carlson AL; Shah VN; Weinstock RS; Bhargava A; Jones TC; Aleppo G; Mehta SN; Laffel LM; Forlenza GP; Sherr JL; Huyett LM; Vienneau TE; Ly TT;
    Diabetes Res Clin Pract; 2022 Aug; 190():109998. PubMed ID: 35853530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
    Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
    J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.